NCT05293002View on ClinicalTrials.gov

Belgian Study to Assess the Efficacy and Safety of the RESTORER Iliac Stent for Treatment of Aorto-iliac Lesions.

NAActive, not recruitingINTERVENTIONAL
Enrollment

131

Participants

Timeline

Start Date

June 13, 2022

Primary Completion Date

July 31, 2025

Study Completion Date

December 31, 2025

Conditions
Peripheral Arterial Disease
Interventions
DEVICE

Restorer Iliac Stent System

Not applicable (only one intervention)

Trial Locations (14)

1800

A.Z. Jan Portaels, Vilvoorde

2610

GZA ziekenhuizen, Antwerp

2650

UZA, Antwerp

2820

Imelda Hospital, Bonheiden

3300

R.Z. Heilig Hart, Tienen

3500

Jessa, Hasselt

3600

Z.O.L., Genk

4000

CHU Liège, Liège

8000

AZ Sint Jan Brugge, Bruges

9000

AZ Maria Middelares, Ghent

9100

Vitaz, Sint-Niklaas

9200

A.Z. Sint-Blasius, Dendermonde

9300

O.L.V. Hospital, Aalst

Unknown

az Groeninge, Kortrijk

Sponsors

Lead Sponsor

ID3 Medical
All Listed Sponsors
lead

ID3 Medical

OTHER

NCT05293002 - Belgian Study to Assess the Efficacy and Safety of the RESTORER Iliac Stent for Treatment of Aorto-iliac Lesions. | Biotech Hunter | Biotech Hunter